Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone for Oral Mucositis Pain in Nasopharyngeal Carcinoma
NCT03045484Unknown
- Sponsor
- Sun Yat-sen University
- Start
- May 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of oxycodone in oral mucositis (OM) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Total Dose of Oxycodone at 3 weeks. Status: unknown.
02
Drugs
oxycodone
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT03045484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03045484.